Beispiel: Heart Attack

Suchen Sie in klinischen Studien nach: Thalidomide

Insgesamt 436 ergebnisse

NCT04680195

Noch nicht rekrutiert

Thalidomide in the Treatment of Chronic Radiation Proctitis With Intractable Bleeding

Bedingungen: Chronic Radiation Proctitis
NCT03184844

Unbekannter Status

The Effective and Safety of Thalidomide in TI

Bedingungen: Thalassemia
NCT02995707

Unbekannter Status

The Effective and Safety of Thalidomide in NTDT

Bedingungen: Thalassemia
NCT01485224

Abgeschlossen

Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia

Bedingungen: Hereditary Hemorrhagic Telangiectasia; Epistaxis
NCT03208413

Rekrutierung

The Therapeutic Effect of Thalidomide in RI

Bedingungen: Radiation Injuries
NCT03016000

Rekrutierung

Thalidomide Maintenance Treatment in DLBCL

Bedingungen: Lymphoma, Large B-Cell, Diffuse
NCT01924624

Unbekannter Status

Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma

Bedingungen: Hepatocellular Carcinoma; Recurrence
NCT00953615

Beendet

Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)

Bedingungen: Primary Sclerosing Cholangitis
NCT02754960

Zurückgezogen

Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding

Bedingungen: Gastrointestinal Hemorrhage; Vascular Malformation
NCT01638078

Unbekannter Status

Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation

Bedingungen: Coronary Artery Disease
NCT03651102

Rekrutierung

Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia

Bedingungen: Thalassemia
NCT00657488

Abgeschlossen

Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma

Bedingungen: Multiple Myeloma
NCT02507336

Aktiv, nicht rekrutierend

Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165

Bedingungen: Mantle Cell Lymphoma; Non-Hodgkin's Lymphoma
NCT02778893

Unbekannter Status

Conmana Combined With Thalidomide to Treat NSCLC

Bedingungen: NSCLC
NCT02203253

Abgeschlossen

Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting

Bedingungen: Neoplasms
NCT02649101

Unbekannter Status

Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer

Bedingungen: Metastatic Breast Cancer
NCT01028781

Beendet

Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With Endometriosis

Bedingungen: Endometriosis
NCT00856804

Unbekannter Status

Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance

Bedingungen: Hepatitis C
NCT01061866

Abgeschlossen

Thalidomide Low Threshold in Epilepsy

Bedingungen: Refractory Epilepsy
NCT03069326

Rekrutierung

A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis

Bedingungen: Myelofibrosis
NCT02956538

Unbekannter Status

Induced Adult Refractory Active Crohn's Disease Clinical Relieving by Using Thalidomide

Bedingungen: Crohn Disease
NCT02501291

Abgeschlossen

Thalidomide in Treating Crohn's Disease

Bedingungen: Crohn's Disease
NCT01937442

Abgeschlossen

Pharmacokinetic Study of Thalidomide in Subjects With Multiple Myeloma

Bedingungen: Multiple Myeloma
NCT02201043

Abgeschlossen

Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis

Bedingungen: Ankylosing Spondylitis
NCT01891019

Abgeschlossen

Thalidomide in the Treatment of Chronic Plaque Psoriasis.

Bedingungen: Psoriasis, Plaque-type